12 years after going public, beleaguered gene therapy company bluebird bio will be sold to private equity groups Carlyle and ...

A one-day blood donation camp for thalassemia patients was held at the Municipal Corporation office on Thursday, with the joint ...

The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...

In recent weeks, Children’s Hospital Los Angeles in East Hollywood has taken steps to improve care for some of its pediatric patients. In late January, ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

First Stem Cell and Genomics Laboratory (FSG), formerly known before as Hortman Stem Cell Laboratory and with the support of the Dubai Health Authority, is organising the third Dubai Stem Cell ...

Like recombinant DNA before it, gene editing has the potential to transform medicine, agriculture and more. CRISPR is now ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to ...

Gushika ico gihe, kurongorwa canke kwitwa umuvyeyi vyari nk'indoto za kure kuri Kinjal, kubera yari afise ikibazo gikomeye ca ...

Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Good morning, and welcome to Agios’ Fourth Quarter 2024 ...